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Predictive factors for treatment success of transforaminal epidural steroid injection in
lumbar disc herniation-induced sciatica
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Background/aim: The aim of this study was to identify predictive factors for treatment success in transforaminal epidural steroid
injection in patients with lumbar disc herniation-induced sciatica.
Materials and methods: A total of 219 patients who were diagnosed with unilateral sciatica and underwent transforaminal epidural
steroid injections at the level of L4-5, L5-S1, or S1 neural foramina between March 2016 and May 2018 were retrospectively analyzed.
The presence of transitional vertebrae and the grade of nerve root compression were evaluated by a radiologist. Data including age, sex,
body mass index, duration of symptoms, injection levels, and pain scores were recorded. Pain scores were evaluated using the numerical
rating scale. Treatment success was defined as a ≥50% decrease in pain scores at 3 months.
Results: The study included 118 female and 101 male patients with a mean age of 43.65 ± 12.18 years. The mean duration of symptoms
was 25.64 ± 2.17 weeks. Although the duration of symptoms was longer in patients for whom treatment failed, it did not reach statistical
significance. Decreased pain scores at 1 h had a significant effect on treatment success (p = 0.012, odds ratio (OR): 1.015, 95% confidence
interval (CI), 1.003–1.026).
Conclusions: Our study results suggest that a decreased pain score at 1 h is a predictor for a favorable three-month response to
transforaminal epidural steroid injection in patients with lumbar disc herniation-induced sciatica.
Key words: Epidural injection, herniated disc, low back pain, back pain with radiation, magnetic resonance imaging, sciatica

1. Introduction
Lumbar disc herniation (LDH)-induced sciatica is a
common health problem with a lifelong prevalence of
12.2%–43% and an annual prevalence of 2.2%–34%
[1]. Pain is triggered by mechanical compression on the
dorsal root or ganglion of the herniated disc material or
inflammation induced by chemokines and enzymes in
the disc [2]. Several studies have shown the short-term
efficacy of transforaminal epidural steroid injection
(TFESI), which is commonly used in clinical practice in the
treatment of sciatica [3,4]. It may exert its effect through
the antiinflammatory and neural membrane stabilization
effect of the steroid injection, increased blood flow of the
ischemic spinal root through the local anesthetic agent,
and removal of cytokines due to the washout effect from
the injection material [5,6]. In addition, TFESI is a targetspecific and a favorable option for delivering the injection
material to the ventral epidural site where pathological
alterations occur [7].

Despite the established short-term efficacy of TFESI
for the treatment of LDH-induced sciatica, similar
treatment outcomes may not be obtained in all patients.
This indicates that there are several factors which affect
treatment success. A number of studies have been carried
out to investigate the clinical and radiological parameters
which can affect TFESI outcomes [8–21]. These studies
have shown that the duration of symptoms before TFESI
has an effect on treatment outcomes with an inverse
correlation between duration of pretreatment symptoms
and treatment outcomes [11,16,21]. Some authors
have demonstrated that duration of symptoms has no
effect on treatment outcomes [10,18]. Spinal nerve root
compression, as assessed by lumbar magnetic resonance
imaging (MRI), has been associated with decreased pain
scores after TFESI, and low-grade nerve root compression
responds better to the treatment [9,10]. In contrast, some
authors found that high-grade spinal nerve compression
positively affects the treatment response or that there
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is no correlation between the grade of the nerve root
compression and treatment outcomes [12,13].
To the best of our knowledge, there is a limited number
of studies investigating possible factors affecting treatment
outcomes in the literature. Therefore, the role of clinical
and radiological parameters on TFESI outcomes has not
been elucidated, and the predictive factors for treatment
success are not clearly understood. In the present study
we aimed to identify predictive factors for successful
treatment through TFESI in patients with LDH-induced
sciatica.
2. Materials and methods
All patients who were diagnosed with LDH-induced
sciatica, as confirmed by physical examination and lumbar
MRI, and who underwent TFESI at standard doses of
corticosteroids and local anesthetics between March
2016 and May 2018 were retrospectively analyzed. Of 826
patients who underwent TFESI, 219 met the inclusion
criteria and were included in the study. Inclusion criteria
were as follows: 18 to 65 years of age; LDH at the level of
L3-4, L4-5, or L5-S1, as evidenced by MRI and TFESI, due
to unilateral L4, L5, or S1 spinal nerve root compression;
and complete three-month follow-up data. Exclusion
criteria were as follows: prior lumbar surgery including
lumbar fusion or laminectomy; lumbar spinal stenosis,
spondylosis, or spondylolisthesis; local or systemic
infections; inflammatory rheumatic diseases such as
ankylosing spondylitis and psoriatic arthritis; history of
malignancy; repeated TFESI during <3-month follow-up
or missing data.
Data including age, sex, body mass index (BMI),
duration of symptoms, and injection levels were recorded.
Pain scores were evaluated before and at 1 h, 3 weeks, and
3 months after TFESI using the numerical rating scale
(NRS). The presence of transitional vertebrae and the grade
of nerve root compression were evaluated by a radiologist.
Treatment success was defined as a ≥50% decrease in
pain scores at 3 months [22,23]. The study protocol
was approved by the ethics committee of the Marmara
University, Faculty of Medicine (no.: 09.2018.591). The
study was conducted in accordance with the principles of
the Declaration of Helsinki. As it is routine practice for
transforaminal epidural steroid injection procedures in
our clinic, all patients were asked to fill out and sign the
standard patient consent form prior to the procedure. The
ethics committee waived the requirement for informed
patient consent because patient recontact was not
established for this study.
2.1. Radiological assessment
The radiologist who was blinded to all clinical data had 7
years of experience in spinal and musculoskeletal imaging.
Cervicothoracic sagittal scout images were accepted as

the gold standard for numbering the lumbar vertebral
segments [24]. The vertebrae were numbered by counting
caudally from C2 with cross-referencing cervicothoracic
and lumbar sagittal MRI scans on the Picture Archiving
and Communication System (PACS) (Carestream Health
Inc., Rochester, NY, USA) workstation using the spinaltagging properties of the software. The presence of lumbar
transitional vertebrae was recorded according to vertebra
count and numbering.
The grade of nerve compression was assessed on axial
T2-weighted images and sagittal T1- weighted images,
respectively. For the classification of spinal nerve root
compression, the modified Pfirrmann grading system
was used for central and subarticular disc herniation [25].
Accordingly, grade I applies when the disc simply contacts
the nerve root; grade II when the nerve root is displaced,
but with preservation of periradicular cerebrospinal
fluid (CSF) or fat; grade III when the periradicular CSF
or fat is obliterated; and grade IV when the nerve root is
morphologically distorted. Grades I and II indicate lowgrade nerve root compression, while grades III and IV
indicate high-grade nerve root compression. No grading
for foraminal herniation was used, due to the lack of data
for foraminal and extraforaminal LDH patients.
2.2. TFESI procedure
All patients were placed in the prone position and
supported with a pillow under the abdomen to reduce
lumbar lordosis. The injection site was cleaned with
povidone–iodine antiseptic 3 times and covered with a
sterile dressing. The arm of the fluoroscope was rotated
obliquely 10°–30° toward the region in the cranial
direction, and the foramen was visualized. Local anesthesia
(3 cc of 2% prilocaine) was administered to the skin and
subcutaneous tissue. A Quincke 3.5-inch 22-gauge spinal
needle was inserted under the intermittent guidance of
fluoroscopy using the coaxial technique and advanced
to the subpedicular space in the 6 o’clock direction. The
needle position was confirmed through a lateral view.
Following confirmation, 1–2 mL of contrast dye was given,
and needle position in the epidural space was confirmed
in anteroposterior and lateral views. Once adequate flow
of contrast dye was achieved without vascular flow, a
mixture of 80 mg of methyl prednisolone acetate, 1 cc of
physiological saline, and 1 cc (0.5%) of bupivacaine was
injected. There were no acute complications after the
TFESI in this study.
2.3. Statistical analysis
Statistical analysis was performed using SPSS for Windows
version 24.0 software (IBM Corp., Armonk, NY, USA).
Descriptive data were expressed as mean ± standard
error of measurement (SEM), number and frequency. The
normality of the distribution of continuous variables was
tested using the Shapiro–Wilk test. The Mann–Whitney
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U test was used to compare 2 independent groups with
abnormally distributed data. The chi-square test was
applied to analyze the relationship between 2 categorical
variables. Multivariate logistic regression analysis was
performed to estimate the odds ratio (OR) and 95%
confidence interval (CI). Univariate and multivariate
regression analyses were carried out to identify possible
predictive factors for treatment success. These factors
included age, sex, symptom duration, BMI, injection level,
the presence of transitional vertebrae, NRS scores before
injections, the grade of nerve root compression, and
postprocedural 1 h NRS score decrement. A p-value of
<0.05 was considered statistically significant.
3. Results
Of the patients, 118 were females and 101 were males with
a mean age of 43.65 ± 12.18 years. The mean duration
of symptoms before injection was 25.64 ± 2.17 weeks.
The most common nerve roots injected in patients were
L5 (50.2%), S1 (47.5%), and L4 (2.3%). Demographic,
radiological, and procedural characteristics are shown in
Table 1.
Of the 219 patients who underwent TFESI, 124 (56.6%)
achieved treatment success in the 3rd month. There was
no significant difference in age, sex, BMI, injection level,
presence of transitional vertebrae, NRS scores before
injections, and the grade of nerve root compression
between patients with and without treatment success
(Tables 2–3). Although the duration of symptoms was
longer in patients for whom treatment failed, it remained
at borderline significance (p = 0.051). There was a higher
decrease in NRS pain scores at 1 h after procedure in
patients for whom treatment was successful (p = 0.024).
Factors with a p-value of ˂0.10 in univariate analysis were
included in the multivariate binary logistic regression
analysis. At the end of the analysis, symptom duration
was not found to be a significant predictor for treatment
success (p = 0.391). Decreased pain scores at 1 h had a
significant effect on treatment success (p = 0.012, OR:
1.015, 95%, CI: 1.003–1.026) (Figure).
4. Discussion
With the recent introduction of spinal interventional
pain management modalities, the number of pain
interventionalists has been on the rise bringing
considerably increased treatment costs [26]. Therefore, it
is of utmost importance for clinicians to identify patients
in whom TFESI could be successful. Hence, predictive
factors which affect the treatment outcomes positively
or negatively should be established. In the present study
we evaluated predictive factors for treatment success of
TFESI in patients with LDH-induced sciatica. Among
all parameters, only decreased pain scores at 1 h after
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Table 1. Demographic,
characteristics.

radiological,

and

procedural

Variable

Value (n = 219)

Age, mean ± SEM (years)

43.65 ± 0.82

Sex

Female

118 (53.9)

Male

111 (46.1)

BMI, mean ± SEM (kg/m²)

27.06 ± 0.29

Mean duration of symptoms (weeks)

25.64 ± 2.17

Level of injection

Nerve root
compression (%)
Transitional
vertebrae

NRS, mean ±SEM

L4-5

5 (2.3)

L5-S1

110 (50.2)

S1 foramen

104 (47.5)

Grade 1

45 (21.5)

Grade 2

54 (25.8)

Grade 3

50 (23.9)

Grade 4

60 (28.7)

Present (%)

18 (8.2)

Absent (%)

201 (91.8)

Before injection

7.33 ± 0.13

Postprocedural 1 h

1.17 ± 0.13

Week 3

3.19 ± 0.18

Month 3

3.84 ± 0.20

BMI: body mass index; NRS: numerical rating scale. Values
expressed as mean ± SEM, number, and frequency, or as
otherwise indicated.

procedure were highly correlated with treatment success
at 3 months.
In another study, Inman et al. [8] evaluated the effect
of epidural steroid injections on pain in patients with low
back pain and reported that sex was not a predictor for
decreased pain scores. This finding is consistent with our
study which showed that sex had no effect on treatment
outcomes. This finding has been supported by several
studies in the literature [9,13,14,18]. In our study age
was not a predictor for treatment success. This may be
because we excluded elderly patients with degenerative
pathologies such as lumbar spinal stenosis or spondylosis
and only included those with LDH-induced sciatica. This
finding is supported in many studies in the literature
[9,11,14,18]. In contrast, Lee et al. [13] showed that mean
age was higher among patients who experienced TFESI
as successful, suggesting that young patients tended to
have more components of the nucleus pulposus, leading
to an inflammatory reaction and more resistant sciatica.
However, these are short-term results. In another study,
Ekedahl et al. [21] reported that a young age at treatment
was a strong predictor for one-year treatment response to

ŞENCAN et al. / Turk J Med Sci
Table 2. Possible categorical variables.
Treatment Success
Successful
(n = 124)

Sex

Level of injection
Grade of nerve root
compression
Transitional vertebrae

Unsuccessful
(n = 95)

n

%

n

%

Female

70

56.5%

48

50.5%

Male

54

43.5%

47

49.5%

S1 foramen

60

48.4%

44

46.3%

L5-S1

60

48.4%

50

52.6%

L4-5

4

3.2%

1

1.1%

Low-grade

55

46.6%

44

48.4%

High-grade

63

53.4%

47

51.6%

Present

9

7.3%

9

9.5%

Absent

115

92.7%

86

90.5%

p
0.383
0.508

0.803
0.554

Table 3. Possible continuous variables.
Treatment Success
Successful (n = 124 )

Unsuccessful (n = 95)

p

Age (years)

43.4 ± 1.14

43.97 ± 1.18

0.616

BMI

27.06 ± 0.39

27.06 ± 0.44

0.776

Duration of Symptoms (weeks)

23.65 ± 2.84

28.24 ± 3.36

0.051

NRS 1 h decrements (%)

88.4 ± 1.89

79.5 ± 2.9

0.024

BMI: body mass index; NRS: numerical rating scale.

TFESI, while BMI was not a predictive factor for threemonth and one-year treatment response. To the best of our
knowledge, there is scarce literature regarding the effect of
BMI on TFESI outcomes. In our study we were unable to
identify BMI as a predictor for treatment outcomes during
a three-month follow-up. This can be attributed to the
small sample size in both studies.
In the present study we applied TFESI mainly at the
L4-5 level, followed by the S1 foramen and L3-4 level. The
injection level was not a predictor for treatment outcomes.
This finding is consistent with our clinical observations.
However, 6 patients underwent TFESI at the L3-4 level.
Although further large-scale studies are needed to obtain
more accurate data, our findings are consistent with the
literature [9,18]. In their study, Son et al. [27] examined
the effect of lumbar transitional vertebrae on the treatment
response to TFESI and reported that sacralized vertebrae
had an adverse effect on treatment outcomes. In the
aforementioned study the authors found sacralization
in 33 of 291 LDH patients. In our study we also found

sacralization in 18 of 219 patients. However, the presence
of transitional vertebrae did not affect treatment outcomes.
This may be explained by the small sample size or the type
of transitional vertebrae.
Spinal nerve root compression, as assessed by lumbar
MRI, has been associated with decreased pain scores
after TFESI, and low-grade nerve root compression
responds better to the treatment [9,10]. Some authors
have suggested that patients with high-grade spinal nerve
root compression respond better to treatment [12,17].
In a retrospective study, Paidin et al. [12] reported that
the higher resorption rates in patients with large disc
herniation were associated with more favorable treatment
responses in patients with high-grade spinal nerve root
compression. In addition, Ekedahl et al. [21] found that
high-grade nerve root compression was a strong predictor
of adverse treatment outcomes during one-year follow-up.
On the other hand, some authors have suggested that there
is no correlation between spinal nerve root compression
and treatment response [13,19], and this was consistent
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Figure. The relationship between decreased pain scores at 1 h after procedure and treatment success.

with our study findings. In our study we included patients
with subarticular/central herniation and excluded those
with foraminal herniation; therefore, we were unable to
evaluate foraminal compression. Further multicenter,
large-scale, prospective studies are required to establish a
definite conclusion.
In the present study duration of symptoms was longer
in patients for whom treatment was successful, indicating
borderline significance. However, regression analysis
revealed that it was not a predictor for treatment success.
This finding is consistent with previous studies which
showed no correlation between duration of symptoms
and treatment outcomes [10,18]. However, several studies
demonstrated that prolonged duration of symptoms
adversely affected treatment response [11,21,22]. The
discrepancy among studies may be caused by the different
sample sizes. In our study the decreased pain scores at 1
h after procedure were highly correlated with treatment
success, indicating that a greater decrease in pain scores may
increase the chance of treatment success. El-Yahchouchi et
al. [15] reported that immediate, post-TFESI relief of index
pain at 2 weeks was weakly associated with longer term
outcomes for pain relief or functional recovery. This result
can be explained by their different definition of treatment
success and short-term follow-up results.
Only pain scores at 1 h after procedure, which is
a postprocedural factor, were highly correlated with
treatment success. Unfortunately, it is not a preprocedural
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factor. Therefore, it will not contribute to predicting
treatment success in patients prior to performing the
procedure. On the other hand, predicting treatment
success at the first hour after the procedure (i.e. in a
short time after the procedure) seems to be valuable for
the patient and physician, as it provides the patient with
objective information about the success of the procedure.
The main strength of our study is the inclusion of a
homogeneous patient population with only LDH-induced
sciatica and the examination of several clinical and
radiological parameters. Nonetheless, the retrospective
design with a short-term follow-up is the main limitation
of this study. In addition, we were unable to analyze other
factors, such as contrast dispersal patterns, in predicting
treatment response.
In conclusion, our study results suggest that decreased
pain scores at 1 h are predictors for a favorable threemonth response to TFESI in patients with LDH-induced
sciatica and can be a useful marker for identifying patients
who would benefit from treatment. Nevertheless, further
multicenter, large-scale, prospective studies are needed to
elucidate possible predictive factors for treatment success.
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